Pershing Square`s Investor Letter provides the backdrop for an analysis or case study on Valeant Pharmaceuticals.
(Video length 00:16:14)
New Posts
Mars to Buy Pringles Maker Kellanova for $36 Billion: A Big Deal in the Snack World
Volvo Cars to Deliver First EX90 SUVs This Month After Delay
Housing Market Filled With ‘Wait-and-See’ Home Buyers
AI Dataset Licensing Companies Form Trade Group
New Tom Hanks Film “Here” and the Unsettling ‘De-Aging’ Technology Keeping Stars Forever Young
Leave A Comment